Trypanosoma cruzi‐infected macrophages are defective in major histocompatibility complex class II antigen presentation
- 6 December 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (12) , 3085-3094
- https://doi.org/10.1002/eji.1830271202
Abstract
Trypanosoma cruzi, the intracellular protozoan parasite that causes Chagas' disease, interferes with the host immune response to establish a persistent infection. In this report, we demonstrate that macrophages infected with T. cruzi are unable to effectively present antigens to CD4 T cells. The interference is due to defective antigen-presenting cell (APC) function, as antigen-independent stimulation of the T cell in the presence of infected macrophages is not affected. The defect is distal to antigen processing and is not due to decreased major histocompatibility complex (MHC) class II expression, decreased viability, defective peptide loading in the infected macrophages, nor absence of CD28 co-stimulation. There was a role for gp39:CD40 co-stimulation during antigen presentation to the T cells we studied, but the expression of CD40 on T. cruzi-infected macrophages was not decreased. Antigen-specific adhesion between macrophages and T cells was reduced by infection. Equivalent levels of the adhesion molecules lymphocyte function-associated antigen-1, intercellular adhesion molecule-1, vascular cell adhesion molecule-1 or very late antigen-4 are found on infected and uninfected APC, suggesting that reduced expression of these adhesion molecules was not responsible for the defect in antigen-specific adhesion. The defective T cell:macrophage adhesion may be due to the reduced expression of other adhesion molecules or other changes in the cell induced by infection. Interfering with MHC class II antigen presentation in infected macrophages may help T. cruzi to blunt the immune response by the host.Keywords
This publication has 41 references indexed in Scilit:
- Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cellsEuropean Journal of Immunology, 1996
- Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritisClinical and Experimental Immunology, 1995
- T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell ProfilesCritical Reviews in Immunology, 1995
- gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory.The Journal of Experimental Medicine, 1994
- Trypanosoma cruzi trans-sialidase and cell invasionParasitology Today, 1993
- Cytoplasmic Domain Heterogeneity and Functions of IgG Fc Receptors in B LymphocytesScience, 1992
- The role of T-cell subpopulations in experimental Chagas' diseaseResearch in Immunology, 1991
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture.The Journal of cell biology, 1991
- The restrictive role of sialic acid in antigen presentation to a subset of human peripheral cd4+ t lymphocytes that requires antigen‐presenting dendritic cellsEuropean Journal of Immunology, 1989